1. Home
  2. DIBS vs WHWK Comparison

DIBS vs WHWK Comparison

Compare DIBS & WHWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 1stdibs.com Inc.

DIBS

1stdibs.com Inc.

HOLD

Current Price

$4.45

Market Cap

194.7M

ML Signal

HOLD

WHWK

Whitehawk Therapeutics Inc.

HOLD

Current Price

$4.74

Market Cap

232.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DIBS
WHWK
Founded
2000
2007
Country
United States
United States
Employees
N/A
23
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
194.7M
232.4M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
DIBS
WHWK
Price
$4.45
$4.74
Analyst Decision
Buy
Strong Buy
Analyst Count
1
2
Target Price
$7.00
$7.50
AVG Volume (30 Days)
171.2K
317.4K
Earning Date
05-08-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
22.45
N/A
EPS
N/A
N/A
Revenue
$89,620,000.00
N/A
Revenue This Year
$3.12
N/A
Revenue Next Year
$1.72
N/A
P/E Ratio
N/A
N/A
Revenue Growth
1.54
N/A
52 Week Low
$2.35
$1.57
52 Week High
$6.62
$5.50

Technical Indicators

Market Signals
Indicator
DIBS
WHWK
Relative Strength Index (RSI) 36.95 61.99
Support Level $4.38 $3.72
Resistance Level $5.74 N/A
Average True Range (ATR) 0.33 0.31
MACD -0.01 0.07
Stochastic Oscillator 50.75 56.99

Price Performance

Historical Comparison
DIBS
WHWK

About DIBS 1stdibs.com Inc.

1stdibs.com Inc is an online marketplace for connecting design lovers with the sellers and makers of vintage, antique, and contemporary furniture, home decor, jewelry, watches, art, and fashion. The company has a single reportable and operating segment that contains one reporting unit, which consists of the company's online marketplace that enables commerce between sellers and buyers. The company generates maximum revenue from fees from seller marketplace services and other services, including advertisements.

About WHWK Whitehawk Therapeutics Inc.

Whitehawk Therapeutics Inc is an oncology therapeutics company applying technologies to tumor biology to develop cancer treatments. Its portfolio includes three antibody-drug conjugate (ADC) candidates designed to address limitations of earlier therapies for patients with difficult-to-treat cancers. The company generates revenue from the sale of its products.

Share on Social Networks: